% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

  • medicalstarw medicalstarw Jun 27, 2013 11:55 AM Flag

    (IGXT) MCap $29 M/ Price 0.57 / NDA accepted by FDA / 10 Drugs in Late Stage !!!

    Unknown Gem with Brutal Upside Potential.

    Another 2 NDA filings and 2-3 Partnerships coming this Year ..Only 20 M on the float ..
    IGXT has the Potential to hit $10++ within 2 Year ! GLTA

    Intelgenx (IGXT)

    Market Cap : $29 M
    Cash: $3 M

    Burn-Rate : $1.2 M a year
    Shares Out : 51 M ( 30 M shares are held by Investors )

    IGXT´s Monster Pipeline :

    Product ......Application......... Status of Development

    INT0004/2006 Antidepressant -- US launch in 4Q 2012

    INT0008/2007 Migraine -- PDUFA Date on Feb 3 2014

    INT0007/2006 Erectile Dysfunction -- NDA filing later in 2013

    INT0001/2004 CHF (Coronary Heart Failure), Hypertension -- ANDA filing later in 2013

    INT0027/2011 Undisclosed Partnered with Par Pharma -- ANDA filing later in 2013

    INT0020/2010 Insomnia -- in Pivotal Study

    INT0024/2010 Idiopathic pulmonary fibrosis -- in Pivotal Study

    INT0028/2011 Cancer pain (cannabinoid) --in Pivotal Study

    INT0030/2011 Animal health -- in Pivotal Study

    INT0031/2012 Benign prostatic hyperplasia --in Pivotal Study


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • First off....Wrong Board!
      Glancing at appears to be that they specialize in drug delivery systems like oral slimes and timed coatings..not that they are inventing new drugs..
      So your promo is kinda deceptive and given that there is considerable competition, the upside is apt to be modest

84.68-1.18(-1.37%)May 6 4:00 PMEDT